Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0LJL stock hub

LON/0LJL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LJLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LJL

In the news

Latest news · LON/0LJL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.2

P25 12.9P50 16.9P75 23.5

Trailing P/E6.6

P25 15.9P50 22.9P75 35.8

ROE21.4

P25 -54.2P50 2.1P75 13.7

ROIC12.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LJL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	101,500
Employees Change	2,500%
Employees Change Percent	2.53
Enterprise value	$11.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US9139031002
Last refreshed	2026-05-10
Market cap	$7.6B
Price	$171
Price currency	USD
Rev Per Employee	149,527.04x
Sector	Healthcare
Sic	8062
Symbol	lon/0LJL
Website	https://uhs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	15.25%
EV Earnings	9.84x
EV/EBIT	7.55x
EV/EBITDA	5.48x
EV/FCF	16.39x
EV/Sales	0.87x
FCF yield	9.15%
Forward P/E	7.24x
P/B ratio	1.31x
P/E ratio	6.56x
P/S ratio	0.56x
PE Ratio10 Y	13.05x
PE Ratio3 Y	11.85x
PE Ratio5 Y	11.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.5%
EBITDA Margin	15.02%
FCF margin	5.14%
Gross margin	44.23%
Gross Profit	$5.9B
Gross Profit Growth	14.35%
Gross Profit Growth Q	13.44%
Gross Profit Growth3 Y	14.25%
Gross Profit Growth5 Y	10.6%
Net Income	$1.2B
Net Income Growth	27.06%
Net Income Growth Q	10.11%
Net Income Growth Quarters	9%
Net Income Growth Years	3%
Net Income Growth3 Y	30.51%
Net Income Growth5 Y	8.58%
Pretax Margin	11.38%
Profit Margin	8.56%
Profit Per Employee	$12,804
Profitable Years	14
ROA	8.35
Roa5y	6.52
ROCE	16.42
ROE	21.37
Roe5y	15.51
ROIC	12.49
Roic5y	10.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-8.09%
Cagr3y	7.57%
Cagr5y	2.94%
Div CAGR3	-3.4%
Div CAGR5	32.96%
EPS Growth	34.83
EPS Growth Q	17.71
EPS Growth Quarters	9
EPS Growth Years	3
EPS Growth3 Y	36.61
EPS Growth5 Y	15.27
FCF Growth	-13.61%
FCF Growth Q	52.43%
FCF Growth3 Y	87.44%
FCF Growth5 Y	-4.27%
OCF Growth	-6.14%
OCF Growth Q	11.55%
OCF Growth10 Y	4.52%
OCF Growth3 Y	31.34%
OCF Growth5 Y	-0.25%
Revenue Growth	10.42x
Revenue Growth Q	9.65x
Revenue Growth Quarters	22x
Revenue Growth Years	13x
Revenue Growth3 Y	9.37x
Revenue Growth5 Y	8.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.16
Assets	$11.9B
Cash	$90.1M
Current Assets	$2.6B
Current Liabilities	$2.4B
Debt	$3.9B
Debt EBITDA	$1.82
Debt Equity	$0.67
Debt FCF	$5.62
Equity	$5.8B
Interest Coverage	13.26
Liabilities	$6.1B
Long Term Assets	$9.3B
Long Term Liabilities	$3.7B
Net Cash	$-3.8B
Net Cash By Market Cap	$-50.22
Net Debt EBITDA	$1.88
Net Debt Equity	$0.66
Net Debt FCF	$5.49
Tangible Book Value	$2.6B
Tangible Book Value Per Share	$43.59
WACC	8.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.08
Inventory Turnover	43.88
Net Working Capital	$731.4M
Quick ratio	0.88
Working Capital	$193.6M
Working Capital Turnover	$26.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.82%
Dividend Growth	-4.27%
Dividend Growth Years	0%
Dividend per share	$0.6
Dividend Years	9
Dividend Yield	0.35%
Ex Div Date	2026-03-02
Last Dividend	$0.15
Payout Frequency	Quarterly
Payout Ratio	3.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-8.08%
200-day SMA	200.4
3Y total return	24.48%
50-day SMA	184.1
50-day SMA vs 200-day SMA	50under200
5Y total return	15.58%
All Time High	246
All Time High Change	-30.41%
All Time High Date	2025-11-26
All Time Low	84.52
All Time Low Change	102.53%
All Time Low Date	2020-04-03
ATR	8.32
Beta	1.3
Ch YTD	-21.95
High	175
High52	246
High52 Date	2025-11-26
High52ch	-30.41%
Low	170
Low52	152
Low52 Date	2025-07-29
Low52ch	12.62%
Ma50ch	-7%
Price vs 200-day SMA	-14.57%
RSI	41.57
RSI Monthly	46.06
RSI Weekly	36.6
Sharpe ratio	-0.1x
Sortino ratio	0.02
Total Return	6.17%
Tr YTD	-21.87
Tr1m	-6.5%
Tr1w	2.77%
Tr3m	-21.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.5B
Operating Income Growth	16.83
Operating Income Growth Q	10.56
Operating Income Growth3 Y	22.64
Operating Income Growth5 Y	7.56
Operating margin	11.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,317,175%
Net Borrowing	39,609,756
Shares Insiders	14.29%
Shares Institutions	86.22%
Shares Qo Q	-2.36%
Shares Yo Y	-5.82%
Short Ratio	2.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$618M
Average Volume	200x
Bv Per Share	93.38
CAPEX	$-752.2M
Ch1m	-6.5
Ch1w	2.77
Ch1y	-8.44
Ch3m	-21.66
Ch3y	22.78
Ch5y	12.66
Ch6m	-25.04
Change	0.02%
Change From Open	0.11
Close	171.1
Days Gap	-0.08
Depreciation Amortization	459,050,665.5
Dollar Volume	59,228.3
Earnings Date	2026-04-27
EBIT	$1.5B
EBITDA	$2B
EPS	$18.17
F Score	7
FCF	$691.2M
FCF EV Yield	6.1x
Financing CF	-666,580,618
Fiscal Year End	December
Founded	1,978
Goodwill	2,919,866,905.2
Graham Number	276.94757
Graham Upside	61.79
Income Tax	$357.9M
Investing CF	-754,955,083
Is Primary Listing	0
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Lynch Fair Value	$224
Lynch Upside	30.82
Ma150	207.2
Ma150ch	-17.37%
Ma20	174.6
Ma20ch	-1.98%
Net CF	21,830,831
Open	171
P FCF Ratio	10.92
P OCF Ratio	5.23
Payment Date	2026-03-16
Position In Range	23.6
Ppne	5,456,583,506
Price Date	2026-05-08
Price EBITDA	$3.74
Ptbv Ratio	2.86
Relative Volume	1.74x
Revenue	13,449,957,176x
SBC By Revenue	0.54x
Share Based Comp	73,153,391
Tax By Revenue	2.66x
Tax Rate	23.39%
Tr6m	-24.9%
Volume	346
Z Score	3.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0LJL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$0.60 annual per share

Payout ratio

+3.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+33.0%

0 consecutive years of growth

Total shareholder yield

+6.2%

Next ex-dividend date: 2026-03-02

Performance

LON/0LJL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LJL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.2%

Share of float held by funds and institutions

Insider ownership

+14.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LJL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-14.6%

50/200-day relationship not available

Beta (5Y)

1.29

More volatile than the market

Sharpe ratio

-0.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LJL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LJL stock rating?

lon/0LJL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LJL analysis?

The full report lives at /stocks/lon/0LJL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LJL?

The latest report frames lon/0LJL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LJL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.